RE-BVS – Piemonte Repository

Sfoglia per AUTORE
ARGOLINI LM
Collezione ASL Città di Torino

Items : 4

Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2022 May 5;61(5):1928-1935. doi: 10.1093/rheumatology/keab611.

2022
ASL Città di Torino
AOU Città della Salute di Torino

Caporali R; Roccatello D; Sinico RA; Miraglia P; Pregnolato F; Tamborini F; Argolini LM; Sciascia S; Moroni G; Schioppo T; Gerosa M;

Chronic glucocorticoid maintenance treatment is associated with the risk of SARS-CoV-2 infection in patients with systemic lupus erythematosus who received vaccination. in Annals of the rheumatic diseases / Ann Rheum Dis. 2022 Aug 3:annrheumdis-2022-222832. doi: 10.1136/ard-2022-222832.

2022
ASL Città di Torino

Gerosa M; Caporali R; Bozzolo EP; Roccatello D; Beretta L; Bellocchi C; Miraglia P; Mescia F; Tamborini F; Moroni G; Sinico RA; Bonelli G; Alberici F; Moroni L; Sciascia S; Schioppo T; Argolini LM; Ramirez GA; Dagna L;

The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study. in Vaccines / Vaccines (Basel). 2022 Apr 22;10(5):663. doi: 10.3390/vaccines10050663.

2022
ASL Città di Torino

Caporali R; Bozzolo E; Dagna L; Roccatello D; Beretta L; Bellocchi C; Miraglia P; Tamborini F; Moroni L; Mescia F; Alberici F; Bonelli G; Sinico RA; Moroni G; Ramirez GA; Sciascia S; Argolini LM; Schioppo T; Gerosa M;

THE IMPACT of ANTI-SARS-COV-2 VACCINES in A MULTICENTER COHORT STUDY of PATIENTS with SYSTEMIC LUPUS ERYTHEMATOSUS in Annals of the Rheumatic Diseases

2022
ASL Città di Torino

Gerosa M; Schioppo T; Argolini LM; Sciascia S; Ramirez GA; Moroni G; Sinico RA; Alberici F; Moroni L; Tamborini F; Miraglia P; Bellocchi C; Beretta L; Roccatello D; Dagna L; Bozzolo E; Caporali R;